YOU ARE HERE > Home > > Bookstore >

Bookstore

The French Generics Market

“The French Generics Market 2017-2022 prospects” report provides a documented, detailed and robust analysis of the French generics and biosimilars markets and evaluates the determinants of their likely evolution by 2022.

Read more
The French Pharma Market

“The French Pharma Market 2016-2022 prospects” report provides a description of the French healthcare system from a legal, organizational and economic point of view. The report also includes a detailed analysis of French pharmaceutical market sales by segment, company and product and an assessment of the impact of its evolution on the pharmaceutical market and pharmaceutical companies by 2022.

Read more
Pharma Marketing Tool Box

The Pharma Marketing Tool Box, second edition, provides a clear, precise and concise review of the key concepts most relevant and useful in the context of pharmaceutical marketing. This user-friendly “tool box” has been designed to be an everyday reference book for both pharmaceutical executives and post-graduate students.

Read more
Drug Value & Market Access Optimization

June 2016 - The "Drug Value & Market Access Optimization" report has been designed as a working tool to help pharmaceutical companies optimize the valuation of their drugs. This report reviews:
- The economic and healthcare environment
- The R&D cost of drugs
- The drug pricing strategic approaches of pharmaceutical companies, governments and payers
- The market access processes in selected countries (France, Germany, Italy, Spain, UK and USA)
- The best practices in market access
The ways to leverage the corporate reputation of pharma companies

Read more
Le marché des génériques en France - Perspectives 2015 - 2020

March 2016 - “Le marché des génériques en France - Perspectives 2015 - 2020” report provides facts and figures about:
- The specificities of the French generics market (retail and hospital) and its evolution, as well as the evolution of the essentially similars and biosimilars markets
- The key regulatory measures and their related impacts
- The competitive environment (originators vs. generics and generics vs. generics)
- The levers to improve the performance of pharma companies

... to help stakeholders better understand the key success factors of this market and to understand its outlook for 2020

Read more
Distribution & Economie de l'officine en France (2014 - 2020)

October 2015 - The “Distribution & Economie de l’officine en France – Perspectives 2020 –” report provides facts and figures about:
- The organization of pharmaceutical distribution in France and its evolution by 2020
- The main regulatory measures and their impact on distribution players
- The levers for improving the economy of pharmacies
- Opportunities for collaboration between pharmaceutical companies and distributors.

Read more
The French Healthcare System and Pharma Market 2015

May 2015 - “The French Healthcare System and Pharmaceutical Market - 2015-2020 prospects & strategic implications for pharmaceutical companies” report provides a description of the French healthcare system from a legal, organizational and economic point of view. The report also includes a detailed analysis of French pharmaceutical market sales by segment, company and product and an assessment of the impact of this evolution on the pharmaceutical market and pharmaceutical companies 2020.

This edition has been updated and enriched (+44% vs. 2014 edition).

Read more
Global Biosimilar Drugs Market Outlooks

February 2015 - The "Global Biosimilar Drugs Market Outlooks" report provides an analysis of the current state of the biosimilar market as well as its perspectives, with a particular focus on the outlooks of the French market over the 2015-2017 period.

Read more
Le marché des génériques en France

October 2014 - “Le marché des génériques en France – 2014” report provides strategic insight into the generics market in France in 2013-2014: environment, regulation, dynamics, companies etc. both on the retail and the hospital markets.

Read more
The French Healthcare System and Pharma Market 2014

June 2014 - “The French Healthcare System and Pharmaceutical Market - 2014 Edition” report provides a description of the French healthcare system from a legal, organizational and economic point of view. The report also includes a detailed analysis of French pharmaceutical market sales by segment, company and product.

Read more
Pharma Market Insight & Strategy - 2013 Edition

November 2013 - “Pharma Market Insight & Strategy (2013 Edition)” provides fact-based analyses to better understand the pharmaceuttical market and to better anticipate its evolution by 2017. The review of the market structure and the identification of its key drivers and limiters, together with the determination of its trends, will be particularly useful for those who wish to reinforce their strategic thinking.

Read more
Biosimilar Drugs Market Perspectives

March 2013 - "Biosimilar drugs market perspectives" is a comprehensive report on the future of biosimilar drugs, with a specific focus on the development prospects of the French market (forecasts 2013-2016).

Read more
The French Healthcare System and Pharma Market - 2013 Edition

May 2013 - “The French healthcare system and pharmaceutical market” report provides an overview of how the French healthcare system works and what are the recent trends in the French pharmaceutical market.

Read more
Comment défendre l'économie de l'officine ?

November 2012 - “Comment défendre l’économie de l’officine ?" provides insight into the economics of French pharmacies, the evolution of the pharmacist role and missions, and the triggers that pharmacists can pull to improve the profitability of their pharmacies.

Read more
Le marché de l'automédication en France

October 2012 - "Le marché de l'automédication en France ?" provides a détailed overview of the French OTC market and its key dynamics, the performances of the main players, as well as the perspectives and winning strategies in this market.

Read more
Pharma Market Insight & Strategy - 2012 Edition

September 2012 - “Pharma Market Insight & Strategy (2012 Edition)” provides fact-based analyses to better understand the pharmaceuttical market and to better anticipate its evolution by 2016. The review of the market structure and the identification of its key drivers and limiters, together with the determination of its trends, will be particularly useful for those who wish to reinforce their strategic thinking.

Read more
The French Generics Market 2012

September 2012 - “The French Generics Market” report provides strategic insight into the generics market in France and will be useful to both original brand and generics companies.

Read more
Contribution of new medias to pharmaceutical marketing

June 2012 - The “Contribution of new medias to pharmaceutical marketing” report provides a description of new medias and how they can be integrated in pharmaceutical companies marketing strategies.

Read more
Pharma Companies Strategies, Key Facts & Figures

October 2011 - “Pharma Companies Strategies – Key Facts & Challenges (2011 Edition)” provides a fact-based analysis of the evolution of the pharmaceutical market and evaluates the strategy and performance of 35 leading pharmaceutical companies. The author shares his strategic vision of where the pharmaceutical market is headed and answers to the question “Does Pharma Companies Size Count?” by comparing the strategic priorities and the corresponding performance of Big Pharma Companies and Mid Pharma Companies.

Read more
Pharma Market Insights, Key Facts & Challenges

June 2010 - “Pharma Market Insights – Key Facts & Challenges (2010 Edition)” provides fact-based analyses to better understand the pharmaceutical market and to better anticipate its evolution by 2014. The review of the market structure and the identification of its key drivers and limiters, together with the determination of its trends, will be particularly useful for those who wish to reinforce their strategic thinking.

Read more